Among these commonly repressed pathways we found several routes that are frequently over-activated in cancer, such as ECM receptor interaction, focal adhesion, mTOR signaling, VEGF signaling, ERBB signaling, TGFβ signaling or WNT signaling (Fig. 7A–B). Here, EGFR is linked to cancer.